Systematic review: Progression of beryllium sensitization to chronic beryllium disease

Occupational Medicine

Volumn 62, Issue 7, 2012, Pages 506-513

  Seidler, A ^a   Euler, U ^b   Muller Quernheim J ^c   Gaede, K I ^d   Latza, U ^b   Groneberg, D ^e   Letzel, S ^f  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b FEDERAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d RESEARCH CENTER BORSTEL   (Germany)

^e GOETHE UNIVERSITY   (Germany)

^f JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Beryllium lymphocyte proliferation test; Beryllium sensitization; Chronic beryllium disease; Exposure cessation; Occupational health practice; Systematic review

Indexed keywords

BERYLLIUM; RADIOISOTOPE;

AIR POLLUTANT; ARTICLE; BERYLLIOSIS; CHRONIC DISEASE; DISEASE COURSE; FEMALE; GERMANY; HUMAN; IMMUNOLOGY; LUNG LAVAGE; LYMPHOCYTE ACTIVATION; MALE; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; PROGNOSIS;

AIR POLLUTANTS, OCCUPATIONAL; BERYLLIOSIS; BERYLLIUM; BRONCHOALVEOLAR LAVAGE FLUID; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; GERMANY; HUMANS; LYMPHOCYTE ACTIVATION; MALE; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; PROGNOSIS; RADIOISOTOPES;

EID: 84867305872     PISSN: 09627480     EISSN: 14718405     Source Type: Journal    
DOI: 10.1093/occmed/kqs069     Document Type: Article

References (22)

1. Müller-Quernheim J, Gaede KI, Prasse A, Zissel G. Chronic berylliosis. Pneumologie 2007;61:109-116 [in German].
2. Rossman MD. Chronic beryllium disease: diagnosis and management. Environ Health Perspect 1996;104(Suppl. 5):945-947.
3. BMAS, ed. Sicherheit und Gesundheit bei der Arbeit 2009. Bericht der Bundesregierung über den Stand von Sicherheit und Gesundheit bei der Arbeit und über das Unfall- und Berufskrankheitengeschehen in der Bundesrepublik Deutschland im Jahre 2009 [Safety and Health at Work 2009. Governmental Report about Safety and Health at Work, Accidents at Work and Occupational Diseases in Germany 2009]. http://osha.europa.eu/fop/germany/de/statistics/statistiken/suga/suga2009/suga_2009.pdf (3 February 2011, date last accessed).
4. Scharkoff T. Epidemiologie der Sarkoidose. Pneumologie 1993;47:588-592.
5. Müller-Quernheim J, Gaede KI, Fireman E, Zissel G. Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients. Eur Respir J 2006;27:1190-1195.
6. Rossman MD, Kern JA, Elias JA, et al. Proliferative response of bronchoalveolar lymphocytes to beryllium. A test for chronic beryllium disease. Ann Intern Med 1988;108:687-693.
7. NRC, Committee on Beryllium Alloy Exposures, Committee on Toxicology, National Research Council. Managing Health Effects of Beryllium Exposure. Washington, DC.: National Academies Press, 2008. http://www.nap.edu/catalog/12464.html (7 April 2011, date last accessed).
8. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 2009;6:e1000097.
9. Scottish Intercollegiate Guidelines Network (SIGN). SIGN 2008. http://www.sign.ac.uk (18 August 2011, date last accessed).
10. Public Health Resource Unit (NHS). Critical Appraisal Skills Programme of the British National Health Service Appraisal Tools CASP 2008. http://www.phru.nhs.uk/Pages/PHD/CASP.htm (18 August 2011, date last accessed).
11. Newman LS, Mroz MM, Balkisson R, Maier LA. Beryllium sensitization progresses to chronic beryllium disease. A longitudinal study of disease risk. Am J Respir Crit Care Med 2005;171:54-60.
12. Duggal M, Deubner DC, Curtis AM, Cullen MR. Longterm follow-up of beryllium sensitized workers from a single employer. BMC Public Health 2010;10:5.
13. Mroz MM, Maier LA, Strand M, Silviera L, Newman LS. Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease. Am J Ind Med 2009;52:762-773.
14. Kreiss K, Mroz MM, Zhen B, Martyny JW, Newman L. Epidemiology of beryllium sensitization and disease in nuclear workers. Am Rev Respir Dis 1993;148:985-991.
15. Newman LS, Lloyd J, Daniloff E. The natural history of beryllium sensitization and chronic beryllium disease. Environ Health Perspect 1996;104(Suppl. 5):937-943.
16. Newman LS, Mroz MM, Maier LA, Daniloff EM, Balkissoon R. Efficacy of serial medical suveillance for chronic beryllium disease in a beryllium machining plant. J Occup Environ Med 2001;43:231-237.
17. Rom WN, Lockey JE, Bang KM, Dewitt C, Johns RE. Reversible beryllium sensitization in a prospective study of beryllium workers. Arch Environ Health 1983;38: 302-307.
18. Thomas CA, Bailey RL, Kent MS, Deubner DC, Kreiss K, Schuler CR. Efficacy of a program to prevent beryllium sensitization among new employees at a copperberyllium alloy processing facility. Public Health Reports 2009;124(Suppl. 1):112-124.
19. Van Dyke MV, Martyny JW, Mroz MM et al. Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers. Am J Respir Crit Care Med 2011;183:1680-1688.
20. Van Dyke MV, Martyny JW, Mroz MM et al. Exposure and genetics increase risk of beryllium sensitization and chronic beryllium disease in the nuclear weapons industry. Occup Environ Med 2011;68:842-848.
21. Lang L. Beryllium: a chronic problem. Environ Health Perspect 1994;102:526-531.
22. Borak J, Woolf SH, Fields CA. Use of beryllium lymphocyte proliferation testing for screening of asymptomatic individuals: an evidence-based assessment. J Occup Environ Med 2006;48:937-947.